These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 6850742)
1. [Essential phospholipids in the treatment of liver cirrhosis]. Kaláb M; Cervinka J Cas Lek Cesk; 1983 Mar; 122(9):266-9. PubMed ID: 6850742 [No Abstract] [Full Text] [Related]
2. [Essential choline phospholipids and their effect on HBsAg and selected biochemical tests in cirrhosis of the liver (author's transl)]. Fassati P; Horejsí J; Fassati M; Spízek J; Jezková Z Cas Lek Cesk; 1981 Jan; 120(2):56-60. PubMed ID: 7471152 [No Abstract] [Full Text] [Related]
3. [Essential colinephospholipids -- an effective and expedient means of hepatic cirrhos freatment (author's transl)]. Fassati P; Fassati M Cas Lek Cesk; 1975 Oct; 114(40):1243-50. PubMed ID: 1102101 [No Abstract] [Full Text] [Related]
4. [Use of "Essenciale" in the treatment of liver diseases]. Pogromov AP; Ol'binskaia LI; Antonenko NI; Gitel' NP; Smolianitskiĭ AIa Klin Med (Mosk); 1978 Oct; 56(10):97-101. PubMed ID: 362064 [No Abstract] [Full Text] [Related]
5. [Alkaline phosphatase isoenzymes in evaluation of therapeutic effect of essential cholinephospholipids in hepatic cirrhoses (author's transl)]. Fassati P; Stĕpán J; Fassati M Cas Lek Cesk; 1976 Jan; 115(2-3):72-5. PubMed ID: 766970 [No Abstract] [Full Text] [Related]
9. Trial of tolbutamide in the treatment of decompensated cirrhosis of liver. Paul D; Nath K; Kumar D J Assoc Physicians India; 1965 Nov; 13(11):875-82. PubMed ID: 5852371 [No Abstract] [Full Text] [Related]
10. [Clinical observation of recombinant growth hormone therapy for liver cirrhosis with hypoproteinemia]. Liu SJ; Tang WL; Shen SR Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):398-400. PubMed ID: 14653129 [TBL] [Abstract][Full Text] [Related]
11. [Colchicine in the treatment of liver cirrhosis. 12 years' experience]. Frysák Z; Hrcková Y Vnitr Lek; 1996 Jan; 42(1):17-9. PubMed ID: 8629353 [TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of bumetanide in the diuretic treatment of heart failure and liver cirrhosis]. Mauro G; Cantino G; Vigiani L Clin Ter; 1981 Mar; 96(5):515-21. PubMed ID: 7285521 [No Abstract] [Full Text] [Related]
14. [Treatment of cirrhosis of the liver by a combination of Lipovitan and orotic acid (author's transl)]. Fassati P; Spízek J; Fassati M Cas Lek Cesk; 1980 Jul; 119(27-28):770-3. PubMed ID: 7428000 [No Abstract] [Full Text] [Related]
15. New therapies in hepatitis C virus and chronic liver disease: antifibrotics. Rockey DC Clin Liver Dis; 2006 Nov; 10(4):881-900. PubMed ID: 17164123 [TBL] [Abstract][Full Text] [Related]
16. Current and prospective therapies for hepatic fibrosis. Trotter JF; Brenner DA Compr Ther; 1995 Jun; 21(6):303-7. PubMed ID: 7664542 [TBL] [Abstract][Full Text] [Related]
17. [Therapy of liver cirrhosis with glucocorticoids]. Loginov AS; Iartseva AM Klin Med (Mosk); 1969 Aug; 47(8):65-71. PubMed ID: 5373414 [No Abstract] [Full Text] [Related]
18. [Treatment of liver cirrhoses with xantinole nicotinate. Results of a double blind study]. Schnack H Munch Med Wochenschr; 1972 Mar; 114(10):460-2. PubMed ID: 5068195 [No Abstract] [Full Text] [Related]
19. [Branched chain amino acids as oral supplements in liver cirrhosis]. Plauth M Z Gastroenterol; 2006 Feb; 44(2):207-8. PubMed ID: 16456764 [No Abstract] [Full Text] [Related]
20. The long-term effects of lamivudine treatment in patients with HBeAg-negative liver cirrhosis. Kilic ZM; Kuran S; Akdogan M; Cicek B; Oguz D; Odemis B; Sasmaz N Adv Ther; 2008 Mar; 25(3):190-200. PubMed ID: 18385953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]